Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

standard is critical to assure the safety, quality, and efficacy of cell culture media in the use of drug components and a testament of the value we bring to our life science customers,” said Ivan Donzelot, Head of Integrated Supply Chain...

Onco360 now offers LAZCLUZE™ (lazertinib) with Rybrevant® for first-line treatment of metastatic non-small cell lung cancer with specific EGFR mutations

lung cancer (NSCLC) whose tumors have EGFR exon 19 deletions of exon 21 L858R mutations, as detected by an FDA-approved test. This new regimen shows superior progression-free survival versus the traditional standard of care. “Onco360 is grateful...

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

Albertsons Companies, Inc. pharmacies are now offering the latest monovalent mRNA COVID vaccines from Pfizer and Moderna along with the annual flu vaccine, in anticipation of a challenging flu and COVID-19 season, as forecasted by the Centers for...

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

capping technology. Pharmaceutical leaders, biotech disruptors, and world governments depend on TriLink to meet their greatest challenges, from delivering the COVID-19 vaccine at warp speed, to empowering innovative treatments in oncology,...

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

a week, including during evenings and weekends. MinuteClinic also offers sick symptom visits during which patients can be tested for flu, COVID-19, and strep throat, if eligible. Appointments can be scheduled at MinuteClinic.com. Select CVS...

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

providing critical comparative data that enables pharmacies to make informed financial decisions, and to support patient testing needs. Updated monthly, the Pharmacy Payor Rate Transparency Monitor will showcase essential billing code data...

BerGenBio selects 2nd dose in Phase 2a STK11m Non-Small Cell Lung Cancer trial.

Safety Monitoring Board (DSMB) for BerGenBio's Phase 1b/2a BGBC016 study confirmed acceptable safety at the highest dose tested in the Phase 1b. As a result, the DSMB also recommended that under the study protocol, no additional patients will be...

Teva and Sanofi Announce Accelerated Anti-TL1A Phase 2b Program for Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) is a chronic autoimmune disorder characterized by chronic inflammation of the gastrointestinal (GI) tract. The two main types of IBD are ulcerative colitis (UC) and Crohn’s disease (CD).1 UC and CD are chronic...

Prolacta Bioscience Leads in Human Milk Science, Regularly Reviewing Health Claims with FDA

Operating the world's first pharmaceutical-grade human milk processing facilities, Prolacta maintains the industry's strictest quality and safety standards, with over 20 validated tests for screening and testing human milk. Prolacta's manufacturing...

Mercury Bio's new project includes Los Alamos and the National Center for Genome Resources.

brings technical expertise and analytical capabilities to this multi-faceted biomolecular research project designed to test and advance the use of yEVs, which are a form of chimeric extracellular vesicle, to deliver assorted large molecule drugs to...

MAIA Biotechnology Announces New Updates from Phase 2 Trial of Novel Cancer Treatment Agent

1, 2 and 3, followed by immune activation on day 4 (no dosing), and cemiplimab 350mg administered on day 5. As of the latest clinical cutoff. 6 patients remain on treatment following at least 12 months of therapy. Treatment with THIO followed by...

Cytoki Pharma Announces Positive Phase 1 Data Showing Potential of CK-0045 to Improve Cardiometabolic Risk Factors

dosing. The most commonly occurring side effects were mild skin reactions and a notable absence of substantial gastrointestinal effects was observed. The available clinical data support advancement of CK-0045 into Phase 2 proof-of-concept studies...

ViroCell Biologics Signs Master Services Agreement With Prominent NCI-Designated Cancer Center

development. Clinical services include global plasmid sourcing, GMP manufacturing, expedited quality control release testing, regulatory filing support, and in-house Qualified Person (QP) batch review and approval for export and use in global...

SHINE Technologies Showcases FLARE™, the World's Most Powerful Continuous Fusion Neutron System

applications in aerospace, defense and energy – including fusion research – by providing necessary radiation for advanced testing of electronics and materials. FLARE also supports national security programs by strengthening the survivability of...

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

and schizoaffective disorder and other prescription medicines (metoclopramide and prochlorperazine) used to treat gastrointestinal disorders are associated with TD. In patients with TD, these treatments are thought to result in irregular dopamine...

Cytonics Begins First-In-Human Phase 1 Clinical Study for CYT-108 in Osteoarthritis Knee Patients

therapeutics for chronic musculoskeletal diseases such as osteoarthritis. The company's flagship product was a diagnostic test (the Fibronectin-Aggrecan Complex Test, FACT) which helps identify the source of joint pain and assists physicians in...

Genentech to Reintroduce Susvimo for Wet Age-related Macular Degeneration (AMD) Treatment

year, Genentech voluntarily recalled the ocular implant, insertion tool and initial fill kit in the U.S. following test results that showed some implants did not perform to Genentech’s standards. Genentech has since updated the Susvimo implant and...

Kedrion Selected by Biotest to Distribute FDA-Approved Immunoglobulin Yimmugo® in the U.S

Kedrion Biopharma Inc. announced that it has established the framework for a long-term agreement with Biotest AG for the full commercialization and distribution of the immunoglobulin therapy Yimmugo® in the U.S., following its Biologic License...

CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis

Care Research at Henry Ford Health and a principal investigator in the CARPO trial. "AP is one of the costliest gastrointestinal diseases for hospitals due to prolonged lengths of stay for severe patients. By reducing the occurrence of severe organ...

Lykos Therapeutics Provides Update on FDA Advisory Committee Meeting for Investigational MDMA-Assisted PTSD Therapy

if approved. We are grateful to the advocates, clinical trial participants and people living with PTSD who shared their testimony in the open public hearing and through written comments, and will continue to do everything we can to bring this...